IMMUNOCIDIN®

Immunocidin® is a veterinary biologic for the treatment of mammary cancer in dogs. It’s based on Bioniche’s proprietary mycobacterial cell wall (MCW) technology platform, derived from Mycobacterium phlei.

Proprietary MCW Technology
Mycobacteria, especially their cell walls, have been known for many years to be active against a variety of tumors. Immunocidin® is an emulsion of mycobacterial cell wall fractions which have been modified to reduce their toxic and allergic effect but retain their immunomodulatory and anti‑tumor activity. Immunocidin® stimulates the activation of a variety of cytokines and lymphocytes which in turn display potent anti‑tumor activity.

For more information please visit: https://www.immunocidin.com/